ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Markets/EquitiesArticle

DNO shares rise 4.4% after strong Q2 2026 earnings

Norwegian oil firm posts better-than-expected quarterly results, lifting shares amid higher crude prices. Full transcript details operational and financial updates.

PA
Priya Anand · Equities & Earnings Desk · 16 Aug 2026 · 1 min read
Share
DNO shares rise 4.4% after strong Q2 2026 earnings

DNO ASA reported stronger-than-expected second-quarter 2026 earnings on Monday, sending its shares up 4.4% in Oslo trading.

The Norwegian oil and gas producer said net profit exceeded analyst estimates, driven by higher realized oil prices and improved production volumes. Operational updates highlighted steady output from its Norwegian continental shelf assets, while costs remained contained.

DNO’s Q2 2026 revenue rose 12% year-over-year, supported by Brent crude prices averaging above $85 per barrel during the quarter. The company reaffirmed its full-year production guidance of 110,000 to 120,000 barrels of oil equivalent per day, citing stable operations across its core assets.

Management noted that exploration activities in the Barents Sea continued to progress, with two new wells scheduled for drilling in late 2026. Cash flow from operations increased 18% sequentially, enabling the company to maintain its dividend policy without adjustments.

Analysts at DNB Markets and Arctic Securities upgraded their price targets on the stock following the results, citing improved visibility on cash flows and operational resilience. DNO’s shares closed at NOK 52.80, up from NOK 50.60 at Friday’s close.

The earnings call transcript is available on the company’s investor relations page.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
ADVERTISEMENT